There Isn’t Enough Data To Justify Banning Breast Implants Linked To Rare Cancer, FDA Decides

But the FDA is considering bold warnings for a type of textured breast implant. The agency’s announcement followed a two-day public hearing in March, in which researchers and implant makers presented data, and women described a number of illnesses they developed after getting implants, including lymphoma.

from Kaiser Health News http://bit.ly/2LlLLXr